Icosavax Insiders
Icosavax employs about 60 people. The company is managed by 13 executives with a total tenure of roughly 140 years, averaging almost 10.0 years of service per executive, having 4.62 employees per reported executive. Break down of Icosavax's management performance can provide insight into the company performance.
Icosavax |
Icosavax Management Team Effectiveness
The company has return on total asset (ROA) of (0.2673) % which means that it has lost $0.2673 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4223) %, meaning that it created substantial loss on money invested by shareholders. Icosavax's management efficiency ratios could be used to measure how well Icosavax manages its routine affairs as well as how well it operates its assets and liabilities.Icosavax Workforce Comparison
Icosavax is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,377. Icosavax holds roughly 60.0 in number of employees claiming about 4% of equities under Health Care industry.
Icosavax Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Icosavax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Icosavax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Icosavax insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Adam Simpson over a year ago Bona fide gift to Adam Simpson of 6532 shares of Icosavax subject to Section 16 | ||
Adam Simpson over a year ago Exercise or conversion by Adam Simpson of 4789 shares of Icosavax subject to Rule 16b-3 | ||
Adam Simpson over a year ago Exercise or conversion by Adam Simpson of 15000 shares of Icosavax subject to Rule 16b-3 | ||
Adam Simpson over a year ago Sale by Adam Simpson of 62205 shares of Icosavax | ||
Russo Thomas Joseph over a year ago Sale by Russo Thomas Joseph of 3066 shares of Icosavax | ||
Shiver John W over a year ago Acquisition by Shiver John W of 17000 shares of Icosavax subject to Rule 16b-3 | ||
Russo Thomas Joseph over a year ago Acquisition by Russo Thomas Joseph of 125000 shares of Icosavax subject to Rule 16b-3 | ||
Adam Simpson over a year ago Exercise or conversion by Adam Simpson of 10677 shares of Icosavax subject to Rule 16b-3 |
Icosavax Notable Stakeholders
An Icosavax stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Icosavax often face trade-offs trying to please all of them. Icosavax's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Icosavax's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David MD | Cofounder Board | Profile | |
| Elizabeth Bekiroglu | General Secretary | Profile | |
| Neil King | Chair CoFounder | Profile | |
| Jennifer Raymond | Senior Operations | Profile | |
| Ami MPH | Senior Affairs | Profile | |
| Mr MPH | Chief Officer | Profile | |
| Niranjan MD | Chief Officer | Profile | |
| Cassia Cearley | Treasurer Officer | Profile | |
| Charles Richardson | VP Operations | Profile | |
| Thomas CFA | Chief Officer | Profile | |
| Lori Stewart | Senior Culture | Profile | |
| Adam Simpson | CEO and President | Profile | |
| David Baker | Cofounder Board | Profile |
Icosavax Workforce Analysis
Traditionally, organizations such as Icosavax use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Icosavax within its industry.Icosavax Manpower Efficiency
Return on Icosavax Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.6M | |
| Net Loss Per Executive | 7.4M | |
| Working Capital Per Employee | 3.5M | |
| Working Capital Per Executive | 16.2M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |